Contact Supplier

Contact Supplier

To get in touch with Bachem AG, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    Oligonucleotides – Innovation that transforms lives

    videosBachem AG
    May 4th 2022

    Emerging as a new treatment option in rare and orphan disease areas, oligonucleotides have matured into a drug class with a broad indication spectrum. The promise of oligonucleotides making a difference to an increasing number of patients.

    With decades of experience in the development, production and regulatory support of APIs, Bachem is extending its focus from peptides to oligonucleotides which leads overall to a transformation of the organization. As can be expected from Bachem, this transformation is being executed meticulously, with a strong focus on innovation and quality. Our aim is to be the first-choice oligonucleotide manufacturer.

    Resources

    Subscribe to Bachems Newsletter to receive the latest updates.

    TRENDING ARTICLE

    Bachem – Partner from Research to Marketed API

    FREE DOWNLOAD

    Contact Bachem AG

    Simply fill out the form below to contact Bachem AG now.

    Send Bachem AG a Message